Vaxin's Unattributed VC Round

Vaxin raised a round of funding on January 22, 2004.

Altimmune, formerly Vaxin, is a clinical stage immunotherapeutic biotechnology company focused on the discovery and development of novel products that engage, stimulate and improve immune responses fo…

Articles about Vaxin's Unattributed VC Round: